These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 29294371)

  • 1. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ketogenic metabolic therapy in malignant glioma: A systematic review.
    Winter SF; Loebel F; Dietrich J
    Crit Rev Oncol Hematol; 2017 Apr; 112():41-58. PubMed ID: 28325264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
    Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
    Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenic Diet for Malignant Gliomas: a Review.
    Thomas JG; Veznedaroglu E
    Curr Nutr Rep; 2020 Sep; 9(3):258-263. PubMed ID: 32720120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments.
    Tang Q; Wu S; Zhao B; Li Z; Zhou Q; Yu Y; Yang X; Wang R; Wang X; Wu W; Wang S
    Biomed Pharmacother; 2024 Sep; 178():117257. PubMed ID: 39137648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
    Gomes AS; Ramos H; Soares J; Saraiva L
    Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered metabolism in cancer: insights into energy pathways and therapeutic targets.
    Tufail M; Jiang CH; Li N
    Mol Cancer; 2024 Sep; 23(1):203. PubMed ID: 39294640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth.
    De Feyter HM; Behar KL; Rao JU; Madden-Hennessey K; Ip KL; Hyder F; Drewes LR; Geschwind JF; de Graaf RA; Rothman DL
    Neuro Oncol; 2016 Aug; 18(8):1079-87. PubMed ID: 27142056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
    Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine Addiction In Gliomas.
    Márquez J; Alonso FJ; Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA
    Neurochem Res; 2017 Jun; 42(6):1735-1746. PubMed ID: 28281102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ketogenic diet for the treatment of malignant glioma.
    Woolf EC; Scheck AC
    J Lipid Res; 2015 Jan; 56(1):5-10. PubMed ID: 24503133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.